MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, net of...
$69,986K
Proceeds from issuance of
preferred stock, net of...
$26,548K
Proceeds from issuance of
common stock for equity...
$65K
Net cash provided by
(used in) financing...
$88,756K
Canceled cashflow
$7,843K
Net increase
(decrease) in cash, cash...
$3,763K
Canceled cashflow
$84,993K
Repayment of debt
borrowings
$5,000K
Payments for tax
withholding on share-based...
$2,843K
Maturities of investments
$35,697K
Stock-based compensation
$3,078K
Amortization of debt-related
costs
$681K
Decrease in other
long-term assets
-$195K
Depreciation and
amortization
$110K
Decrease in inventories
-$5K
Net cash (used in)
provided by investing...
-$70,263K
Net cash used in
operating activities
-$14,730K
Canceled cashflow
$35,697K
Canceled cashflow
$4,069K
Purchases of investments
$105,960K
(increase) decrease in
accounts receivable, net
$9,395K
Decrease in accounts
payable and other...
-$6,899K
Net loss
-$1,043K
Other non-cash
adjustments
$581K
Accretion of marketable
securities purchased at a...
$562K
(increase) decrease in
prepaid expenses and...
$319K
Back
Back
Cash Flow
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)
source: myfinsight.com